About Immucura

This author has not yet filled in any details.
So far Immucura has created 53 blog entries.

A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma

2021-11-22T10:34:24+00:00November 19th, 2021|

A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma Treatment scheme CONTACT US Summary This study focuses on the [...]

Phase I/II clinical trial of modulated electro- hyperthermia treatment in patients with relapsed, refractory or progressive heavily treated ovarian cancer

2021-11-14T07:06:16+00:00November 11th, 2021|

Phase I/II clinical trial of modulated electro- hyperthermia treatment in patients with relapsed, refractory or progressive heavily treated ovarian cancer Stages of ovarian cancer CONTACT US Summary This [...]

Retrospective observational Clinical Study on Relapsed Malignant Gliomas Treated with Electro-hyperthermia

2021-11-14T08:37:36+00:00November 11th, 2021|

Retrospective observational Clinical Study on Relapsed Malignant Gliomas Treated with Electro-hyperthermia Brain scans CONTACT US Summary This study aims to evaluate the efficacy and tolerability of electro-hyperthermia (ET) for [...]

Immune Responses and Long-Term Disease Recurrence Status After Telomerase-Based Dendritic Cell Immunotherapy in Patients with Acute Myeloid Leukemia

2021-12-05T08:10:09+00:00November 4th, 2021|

Immune Responses and Long-Term Disease Recurrence Status After Telomerase-Based Dendritic Cell Immunotherapy in Patients with Acute Myeloid Leukemia Results CONTACT US Summary In the current study, [...]

A novel allogeneic off-the-shelf Dendritic Cell Vaccine for post- remission treatment of elderly patients with Acute Myeloid Leukemia

2021-12-05T08:11:10+00:00November 4th, 2021|

A novel allogeneic off-the-shelf Dendritic Cell Vaccine for post- remission treatment of elderly patients with Acute Myeloid Leukemia % of proliferation CONTACT US Summary The options [...]

Phase II Study of Autologous Monocyte-Derived mRNA Electroporated Dendritic Cells (TriMixDC-MEL) Plus Ipilimumab in Patients with Pretreated Advanced Melanoma

2021-12-05T08:01:32+00:00November 4th, 2021|

Phase II Study of Autologous Monocyte-Derived mRNA Electroporated Dendritic Cells (TriMixDC-MEL) Plus Ipilimumab in Patients with Pretreated Advanced Melanoma Pre and post response CONTACT US Summary The [...]

Go to Top